HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
$1.47
After Hours:(0.68%)+0.0100
$1.48
Closed: Mar 25, 5:26:25 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Previous close
$1.44
Day range
$1.43 - $1.51
Year range
$0.87 - $3.19
Market cap
89.19M USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.32M | -13.73% |
Net income | -3.63M | -1.59% |
Net profit margin | — | — |
Earnings per share | -0.14 | 30.61% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.66M | -9.82% |
Total assets | 9.70M | -4.44% |
Total liabilities | 7.33M | 12.39% |
Total equity | 2.38M | — |
Shares outstanding | 60.67M | — |
Price to book | 24.00 | — |
Return on assets | -100.46% | — |
Return on capital | -892.91% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.63M | -1.59% |
Cash from operations | -7.02M | -79.64% |
Cash from investing | — | — |
Cash from financing | 4.80M | -0.89% |
Net change in cash | -2.23M | -345.32% |
Free cash flow | -8.86M | -299.86% |
About
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Founded
2018
Headquarters
Website
Employees
13
